Cellular Health Screening/Health Testing Market by Type (Single (Telomere, Oxidative Stress, Inflammation, Heavy Metal), Multitest), Sample (Blood, Saliva, Serum, Urine), Collection Site (Home, Office, Hospital, Diagnostic Labs), and Region - Global Forecast to 2022
- Advertising -
“Cellular Health Screening Market Projected To Grow at a CAGR of 10.0% from 2017 to 2022.”
The global cellular health screening/Health testing market is expected to reach USD 3.42 billion by 2022 from USD 2.12 billion in 2017, at a CAGR of 10.0% during the forecast period. Inquire For Complete Report Copy of Cellular Health Screening Market report at www.reportsnreports.com/contacts/i…spx?name=1130417
Increasing adoption of telomere performance programs for leading a healthy life; growing focus on increasing healthy life expectancy (HALE); increasing government focus towards preventive healthcare; rising geriatric population and the subsequent growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach for the availability of kits; and increasing burden of chronic diseases are driving the growth of the global cellular health screening market. On the other hand, problems associated with the transport of samples and differences in the cost of test kits offered by different companies may hinder the growth of the market in the coming years.
“The multi-test panels are expected to witness high growth during the forecast period.”
Based on type, the global cellular health screening market is segmented into single test panels and multi-test panels.
- Advertising -
Multi-test panels are expected to register the highest CAGR during the forecast period. The preference for multi-test panels is increasing in the market as they provide results for multiple biomarkers in a single exam.
Cellular Health Screening/Health Testing Market by type 2017-2022 by new Service spreads across 140 pages profiling 15 companies and supported with 71 tables and 32 figures available at ReportsnReports.com
Pharmaceutical & biotechnology companies segment is expected to witness the highest growth
The Cellular Health Screening/Health Testing market is classified on the basis of end users into academic research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies. Pharmaceutical & biotechnology companies are expected to grow at the highest CAGR during the forecast period.
Fundamental of Table of Content
Cellular Health Screening Market, By Type
- Single Test Panels
- Telomere Tests
- Oxidative Stress Tests
- Inflammation Tests
- Heavy Metals Tests
- Multi-Test Panels
Cellular Health Screening Market, By Sample Collection Site
- At-Home Sample Collection
- In-Office Sample Collection
- Other Sites
11 Company Profiles
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships)*
11.1 Telomere Diagnostics, Inc. (TDX)
11.2 Spectracell Laboratories
11.3 Life Length
11.4 Repeat Diagnostics Inc. (Repeat DX)
11.6 Cell Science Systems
11.7 Quest Diagnostics
11.8 Labcorp Holdings
11.9 Biorefrence Laboratories
11.10 Cleveland Heartlab, Inc.
11.11 Genova Diagnostics
11.12 Zimetry LLC
11.13 Immundiagnostik AG
11.14 Segterra, Inc.
11.15 DNA Labs India
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.